Funding profile · Pharmacy software

MedMe Health

A Toronto pharmacy software company with about C$4.7 million in reported equity through 2022 and an undisclosed CIBC credit facility from August 2025. No SEC Form D was found.

C$4.7MTotal equity raised as of Mar 2022, per BetaKit
C$3.4MSeed led by M12, announced Mar 17, 2022 (US$2.7M)
C$750KPre-seed led by MaRS IAF, about a year earlier
0Form D filings found for MedMe or a related vehicle

Data as of September 22, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2019 to 2020 Pre-seed C$750,000 MaRS Investment Accelerator Fund (lead) BetaKit
2020 Pitch competition prizes C$100,000 Velocity; C$70,000 Wefunder event Velocity Fund; Wefunder Waterloo News
Winter 2021 Y Combinator W21 Not disclosed Y Combinator Company blog
Jan to Mar 2022 Seed, all equity C$3.4M (US$2.7M) M12 (lead), Graphite Ventures, MaRS IAF, Y Combinator BetaKit, counsel
Aug 20, 2025 Growth credit facility Not disclosed CIBC Innovation Banking Business Wire

What the filings show

MedMe Health · Form D · none found

Search
Pipeline records held zero parsed Form D filings and zero EDGAR Form D mentions for the company name
Vehicles
No SPV or investment vehicle naming MedMe was found
US entity
Not identified in any source
Canadian entity
MedMe Health Limited, Ontario. Incorporation date and corporation number not confirmed

Reading the filings

  1. The seed is missing from EDGAR, which is normal for a Canadian issuer.The round closed in Ontario, with Canadian counsel. Investors were Canadian and US funds, and a US Form D is only required where securities are sold to US investors under Regulation D. M12 and Y Combinator are US investors, so a filing was possible, but none was found.
  2. The totals nearly reconcile.C$750,000 pre-seed plus C$3.4M seed is C$4.15M. Adding the C$100,000 and C$70,000 competition awards gives C$4.32M. BetaKit’s C$4.7M total leaves about C$380,000 unexplained, which could be the Y Combinator investment or other angels. No source itemizes it.
  3. The currency headline differs by outlet, not by fact.The release says US$2.7M and BetaKit says C$3.4M. Both describe one round. Tracxn shows a total of $3.69M, which matches BetaKit’s US$3.7M and excludes the 2025 debt.
  4. The 2025 facility is debt, not equity.CIBC Innovation Banking described a “growth-focused credit facility” with no size, rate or warrants disclosed. Tracxn shows a masked amount for the same date, so the figure cannot be read.
  5. Four and a half years without a disclosed equity round.The last named equity financing closed in early 2022. The 2025 release lists the same investors: M12, Graphite Ventures, MaRS IAF and Y Combinator. Any later equity raise is not visible in the sources found.

Commercial signals

Signal Detail Source type
Canadian chains Rexall, Shoppers Drug Mart, Jean Coutu Group, Guardian, IDA, The Medicine Shoppe, Remedy’sRx and Pharmasave named in the 2022 release. BetaKit repeats four. Company-stated
Shoppers deployment Shoppers Drug Mart booking page on MedMe’s domain, 36 web archive captures from Nov 2021 to Aug 2026. Web archive
Footprint 1,100 pharmacies (Mar 2021), 3,600 (Mar 2022), 4,500+ (2025 and 2026). Company-stated
Volume 25M+ patient services (Nov 2023 and Aug 2025), 30M+ interactions on the 2026 site. Company-stated
Team size 75 employees, per Tracxn. Data aggregator
US traction Georgia launch announced 2022. AI Scribe and medical billing for US pharmacies since 2024. No named US customer. Not found

What to watch

  • A Form D for any US financing or SPV formed around MedMe.
  • The size and terms of the CIBC facility, if it appears in a lender or company filing.
  • A named US enterprise pharmacy customer.
  • A new equity round, since the last one is now more than four years old.

The MedMe Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • LSK Technologies: Shared investor: Graphite Ventures. A toaster sized plate reader, built by two graduate students from off the shelf parts, that read paper based Zika tests on hundreds of patient samples in Brazil
  • Avro Life Science: Shared investor: Velocity Fund. Two University of Waterloo first years set out to put a generic allergy pill into a sticker
  • Zergo: Shared investor: Velocity Fund. A Waterloo nanotechnology team built a cannabis breathalyzer, then pointed the same electrochemical sensor at fertility hormones in urine
  • Vena Medical: Shared investor: Velocity Fund. A sub-millimetre camera that looks forward from inside a brain artery, and a balloon catheter built to pull a clot out on the first try

Sources

  1. IndependentMicrosoft leads MedMe’s $3.4 million CAD seed roundBetaKit · Mar 17, 2022
  2. IndependentMedMe Health Limited secures $C3.4 million seed financing roundFasken · Mar 2022
  3. IndependentAlumnus digital platform expands pharmacy careWaterloo News
  4. IndependentMedMe Health company profileTracxn · 2026
  5. IndependentCIBC Innovation Banking provides growth capital to venture backed MedMePrivate Capital Journal · Aug 20, 2025
  6. Web archiveShoppers Drug Mart scheduling page on MedMe domainInternet Archive · 2021 to 2026
  7. CompanyHealth Technology Start-up MedMe Health Secures $2.7 Million Seed Investment led by M12PR Newswire · Mar 17, 2022
  8. CompanyCIBC Innovation Banking Provides Growth Capital Financing to MedMe HealthBusiness Wire · Aug 20, 2025
  9. CompanyMedMe Health Joins Y Combinator (W21)MedMe blog · Mar 23, 2021

Compiled from SEC and other public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in MedMe Health. This page is not an offer to sell or a recommendation to buy any security.